Elisa C. Toffoli

Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions

Vladimir Bobkov, Aurélien Zarca, Anneleen Van Hout et al. · Biochemical Pharmacology · 2018 · 69 citations · Full text

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin

Maurice J. D. L. van der Vorst, Elisabeth C. W. Neefjes, Elisa C. Toffoli et al. · BMC Cancer · 2019 · 43 citations · Full text

Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study

Elisa C. Toffoli, Maike G. Sweegers, Hetty J. Bontkes et al. · Physiological Reports · 2021 · 30 citations · Full text

A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors

Lisa A. King, Elisa C. Toffoli, Myrthe Veth et al. · Cancer Immunology Research · 2023 · 27 citations

Adaptive Immune System, Immunology, Immune Regulation +20

Local safety of immediate reconstruction during primary treatment of breast cancer. Direct-to-implant versus expander-based surgery

Egidio Riggio, Elisa C. Toffoli, Caterina Tartaglione et al. · Journal of Plastic Reconstructive & Aesthetic Surgery · 2018 · 23 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +10